학술논문

Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma
Document Type
Article
Source
In Leukemia Research November 2017 62:91-97
Subject
Language
ISSN
0145-2126